IL176564A - Sulfonamide derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof for the manufacture of a medicament having beta2 agonist activity - Google Patents

Sulfonamide derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof for the manufacture of a medicament having beta2 agonist activity

Info

Publication number
IL176564A
IL176564A IL176564A IL17656406A IL176564A IL 176564 A IL176564 A IL 176564A IL 176564 A IL176564 A IL 176564A IL 17656406 A IL17656406 A IL 17656406A IL 176564 A IL176564 A IL 176564A
Authority
IL
Israel
Prior art keywords
hydroxy
phenyl
amino
ethyl
methylpropyl
Prior art date
Application number
IL176564A
Other languages
English (en)
Other versions
IL176564A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34890770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL176564(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0406387A external-priority patent/GB0406387D0/en
Priority claimed from PCT/IB2005/000086 external-priority patent/WO2005080313A2/fr
Application filed by Pfizer filed Critical Pfizer
Publication of IL176564A0 publication Critical patent/IL176564A0/en
Publication of IL176564A publication Critical patent/IL176564A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
IL176564A 2004-01-22 2006-06-26 Sulfonamide derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof for the manufacture of a medicament having beta2 agonist activity IL176564A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290169 2004-01-22
GB0406387A GB0406387D0 (en) 2004-03-22 2004-03-22 Sulfonamide derivatives for the treatment of diseases
US60026004P 2004-08-09 2004-08-09
PCT/IB2005/000086 WO2005080313A2 (fr) 2004-01-22 2005-01-12 Derives de sulfonamides utilises dans le traitement de maladies

Publications (2)

Publication Number Publication Date
IL176564A0 IL176564A0 (en) 2006-10-31
IL176564A true IL176564A (en) 2011-11-30

Family

ID=34890770

Family Applications (1)

Application Number Title Priority Date Filing Date
IL176564A IL176564A (en) 2004-01-22 2006-06-26 Sulfonamide derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof for the manufacture of a medicament having beta2 agonist activity

Country Status (6)

Country Link
CR (1) CR9838A (fr)
CY (1) CY1107107T1 (fr)
EC (1) ECSP066700A (fr)
HR (1) HRP20070542T3 (fr)
IL (1) IL176564A (fr)
MA (1) MA28302A1 (fr)

Also Published As

Publication number Publication date
HRP20070542T3 (en) 2008-02-29
IL176564A0 (en) 2006-10-31
ECSP066700A (es) 2006-10-31
MA28302A1 (fr) 2006-11-01
CY1107107T1 (el) 2012-10-24
HK1096379A1 (zh) 2007-06-01
CR9838A (es) 2008-04-21

Similar Documents

Publication Publication Date Title
CA2553789C (fr) Derives de sulfonamides utilises dans le traitement de maladies
EP1708992B1 (fr) Dérivés des sulfonamides pour le traitement des maladies
AU2005225632B2 (en) Formamide derivatives useful as adrenoceptor
WO2005092861A1 (fr) Derives de quinolinone compositions pharmaceutiques contenant ces derives et utilisation de celles-ci
WO2005092841A1 (fr) Composes presentant une activite beta-agoniste
WO2005090288A1 (fr) Derives de phenylaminoethanol utilises comme agonistes du recepteur beta 2
WO2005092860A1 (fr) Composes servant au traitement de maladies
EP3325452B1 (fr) Composés de benzène sulfonamide thiazole hydrophobes et leur utilisation dans le traitement du cancer
EP1577291A1 (fr) Dérivés béta-2 agonistes de la phényléthanolamine
EP1574501A1 (fr) Dérivés de quinoléinone, compositions pharmaceutiques les contenant et leur usage
MXPA06007786A (es) Derivados de sulfonamida para el tratamiento de enfermedades
IL178102A (en) Formamide derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy
HK1096083B (en) Sulfonamide derivatives for the treatment of diseases
HK1096379B (en) Sulfonamide derivatives for the treatment of diseases
HK1096379A1 (zh) 用於治疗疾病的磺酰胺衍生物

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees